Impact of polyunsaturated vegetable oils on adiponectin levels, glycaemia and blood lipids in individuals with type 2 diabetes: A randomised, double-blind intervention study

Journal of Human Nutrition and Dietetics

Volumn 27, Issue 5, 2014, Pages 468-478

  Mullner E ^a   Plasser, E ^a   Brath, H ^b   Waldschutz W ^b   Forster, E ^b   Kundi, M ^c   Wagner, K H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Diabetes Outpatient Clinic   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adiponectin; Diabetes; Intervention; Polyunsaturated fatty acid; Secondary prevention

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; ANTIDIABETIC AGENT; EDIBLE OIL; LIPID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; VEGETABLE OIL;

ADVERSE EFFECTS; AGED; AUSTRIA; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; DIABETIC DIET; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERGLYCEMIA; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADIPONECTIN; AGED; AUSTRIA; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; DIABETIC DIET; DIETARY FATS, UNSATURATED; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; PLANT OILS; RISK FACTORS;

EID: 84927579537     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/jhn.12168     Document Type: Article

References (38)

1. Abbasi, F., Chu, J.W., Lamendola, C., McLaughlin, T., Hayden, J., Reaven, G.M. & Reaven, P.D. (2004) Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53, 585-590.
2. Almario, R.U., Vonghavaravat, V., Wong, R. & Kasim-Karakas, S.E. (2001) Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am. J. Clin. Nutr. 74, 72-79.
3. Asp, M.L., Collene, A.L., Norris, L.E., Cole, R.M., Stout, M.B., Tang, S.Y., Hsu, J.C. & Belury, M.A. (2011) Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: a randomized, double-masked, crossover study. Clin. Nutr. 30, 443-449.
4. Banga, A., Unal, R., Tripathi, P., Pokrovskaya, I., Owens, R.J., Kern, P.A. & Ranganathan, G. (2009) Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am. J. Physiol. Endocrinol. Metab. 296, E480-E489.
5. Blümer, R.M., van der Crabben, S.N., Stegenga, M.E., Tanck, M.W., Ackermans, M.T., Endert, E., van der Poll, T. & Sauerwein, H.P. (2008) Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans. Am. J. Physiol. Endocrinol. Metab. 295, E613-E617.
6. Cui, X.B., Wang, C., Li, L., Fan, D., Zhou, Y., Wu, D., Cui, Q.H., Fu, F.Y. & Wu, L.L. (2011) Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 Pathway. Cardiovasc. Res. 93, 69-78.
7. Danaei, G., Finucane, M.M., Lu, Y., Singh, G.M., Cowan, M.J., Paciorek, C.J., Lin, J.K., Farzadfar, F., Khang, Y.H., Stevens, G.A., Rao, M., Ali, M.K., Riley, L.M., Robinson, C.A. & Ezzati, M.; on behalf of the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378, 31-40.
8. Davis, S.N. (2008) Diabetic dyslipidemia and atherosclerosis. Clin. Cornerstone 9, S17-S27.
9. Duda, M.K., O'shea, K.M., Lei, B., Barrows, B.R., Azimzadeh, A.M., McElfresh, T.E., Hoit, B.D., Kop, W.J. & Stanley, W.C. (2007) Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc. Res. 76, 303-310.
10. Duda, M.K., O'shea, K.M., Tintinu, A., Xu, W., Khairallah, R.J., Barrows, B.R., Chess, D.J., Azimzadeh, A.M., Harris, W.S., Sharov, V.G., Sabbah, H.N. & Stanley, W.C. (2009) Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc. Res. 81, 319-327.
11. Haban, P., Zidekova, E. & Klvanova, J. (2000) Supplementation with long-chain n-3 fatty acids in non-insulin-dependent diabetes mellitus (NIDDM) patients leads to the lowering of oleic acid content in serum phospholipids. Eur. J. Nutr. 39, 201-206.
12. Harris, W.S. (1997) n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65, 1645S-1654S.
13. Hopkins, T.A., Ouchi, N., Shibata, R. & Walsh, K. (2007) Adiponectin actions in the cardiovascular system. Cardiovasc. Res. 74, 11-18.
14. Hu, G., Qiao, Q. & Tuomilehto, J. (2001) Glucose tolerance and cardiovascular mortality. Cardiovasc. Rev. Rep., 22, 649-654.
15. Jakob, E. & Elmadfa, I. (1995) Rapid HPLC assay for the assessment of vitamin K1, A, E and beta-carotene status in children (7-19 years). Int. J. Vitam. Nutr. Res. 65, 31-35.
16. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. & Tobe, K. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792.
17. Katan, M.B., Grundy, S.M., Jones, P., Law, M., Miettinen, T. & Paoletti, R. (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 78, 965-978.
18. Kim, B., Jang, Y., Paik, J.K., Kim, O.Y., Lee, S.-H., Ordovas, J.M. & Lee, J.H. (2010) Adiponectin gene polymorphisms are associated with long-chain ω3-polyunsaturated fatty acids in serum phospholipids in nondiabetic Koreans. J. Clin. Endocrinol. Metab. 95, E347-E351.
19. Krey, G., Braissant, O., L'horset, F., Kalkhoven, E., Perroud, M., Parker, M.G. & Wahli, W. (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11, 779-791.
20. Lautamäki, R., Rönnemaa, T., Huupponen, R., Lehtimäki, T., Iozzo, P., Airaksinen, K.E., Knuuti, J. & Nuutila, P. (2007) Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease. Metabolism 56, 881-886.
21. Montori, V.M., Farmer, A., Wollan, P.C. & Dinneen, S.F. (2000) Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 23, 1407-1415.
22. Mostowik, M., Gajos, G., Zalewski, J., Nessler, J. & Undas, A. (2013) Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease. Cardiovasc. Drugs Ther. 27, 289-295.
23. Nawrocki, A.R., Rajala, M.W., Tomas, E., Pajvani, U.B., Saha, A.K., Trumbauer, M.E., Pang, Z., Chen, A.S., Ruderman, N.B., Chen, H., Rossetti, L. & Scherer, P.E. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J. Biol. Chem. 281, 2654-2660.
24. Neschen, S., Morino, K., Rossbacher, J.C., Pongratz, R.L., Cline, G.W., Sono, S., Gillum, M. & Shulman, G.I. (2006) Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-gamma-dependent mechanism in mice. Diabetes 55, 924-928.
25. Norris, L.E., Collene, A.L., Asp, M.L., Hsu, J.C., Liu, L.F., Richardson, J.R., Li, D., Bell, D., Osei, K., Jackson, R.D. & Belury, M.A. (2009) Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. Am. J. Clin. Nutr. 90, 468-476.
26. Piironen, V., Toivo, J. & Lampi, A.M. (2002) New data for cholesterol contents in meat, fish, milk, eggs and their products consumed in Finland. J. Food Compos. Anal. 15, 705-713.
27. Schulz, L.O., Bennett, P.H., Ravussin, E., Kidd, J.R., Kidd, K.K., Esparza, J. & Valencia, M.E. (2006) Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 29, 1866-1871.
28. Shibata, R., Ouchi, N. & Murohara, T. (2009) Adiponectin and cardiovascular disease. Circ. J. 73, 608-614.
29. Tapsell, L.C., Batterham, M.J., Teuss, G., Tan, S.Y., Dalton, S., Quick, C.J., Gillen, L.J. & Charlton, K.E. (2009) Long-term effects of increased dietary polyunsaturated fat from walnuts on metabolic parameters in type II diabetes. Eur. J. Clin. Nutr. 63, 1008-1015.
30. Taskinen, M.R. (2002) Diabetic dyslipidemia. Atheroscler. Suppl. 3, 47-51.
31. Tsao, T.S., Lodish, H.F. & Fruebis, J. (2002) ACRP30, a new hormone controlling fat and glucose metabolism. Eur. J. Pharmacol. 440, 213-221.
32. Wagner, K.H., Auer, E. & Elmadfa, I. (2000) Content of trans fatty acids in margarines, plant oils, fried products and chocolate spreads in Austria. Eur. Food Res. Technol. 210, 237-241.
33. Whiting, D.R., Guariguata, L., Weil, C. & Shaw, J. (2011) IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 94, 311-321.
34. Xu, H.E., Lambert, M.H., Montana, V.G., Parks, D.J., Blanchard, S.G., Brown, P.J., Sternbach, D.D., Lehmann, J.M., Wisely, G.B., Willson, T.M., Kliewer, S.A. & Milburn, M.V. (1999) Molecular recognition of fatty acids by peroxisome proliferator- activated receptors. Mol. Cell 3, 397-403.
35. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P. & Kadowaki, T. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946.
36. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagai, R., Kahn, B.B. & Kadowaki, T. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295.
37. Yu, J.G., Javorschi, S., Hevener, A.L., Kruszynska, Y.T., Norman, R.A., Sinha, M. & Olefsky, J.M. (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51, 2968-2974.
38. Zibaeenezhad, M.J., Rezaiezadeh, M., Mowla, A., Ayatollahi, S.M. & Panjehshahin, M.R. (2003) Antihypertriglyceridemic effect of walnut oil. Angiology 54, 411-414.